patent/EA-199700185-A1

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate	1996-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	1997-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EA-199700185-A1
titleOfInvention	METHOD OF REDUCING THE RISK OF VERBAL FRACTURES
abstract	Alendronate, a bisphosphonate, when administered daily for a significant period of time, has the ability to reduce the level of vertebral fractures in postmenopausal women. It can reduce the number and severity of fractures. The introduction of alendronate can also prevent spinal deformity and growth reduction.
priorityDate	1995-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554994

Total number of triples: 20.